CAS: 24583-23-1; (R)-3-Mercapto-2-Ureidopropanoic Acid

该化合物是氨酸丙酸基丙烷的衍生物,其特点是与细胞骨柱相连的氨基碳基化合物组,该化合物的特点是硫醇(-SH),这是细胞细胞的标志,有助于其反应和形成分解结的能力.氨基碳基化合物组引入了其他功能特性,使其有可能成为各种生物化学应用的候选产品,包括peptide合成和药物开发的建筑块.N-(氨基碳基)-L-cysteine由于极性功能组的存在,在水中通常可以溶解,因为它在生物系统中的生物利用能力得到加强.其结构特性允许它参与红毒反应,并可能在涉及氧化性压力的细胞过程中发挥作用.与许多氨基酸衍生物一样,其稳定性和再活性会受到pH和温度的影响,因此在实验环境中考虑这些因素非常重要.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

(2)-thiazoline-4-carboxylic acid2-amino-(2)-thiazoline-4-carboxylic acid

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2022243244-A1
    优先权日:2019-10-10
    标 题 :Compositions and methods for in vivo synthesis of unnatural polypeptides
    发明人:ROMESBERG FLOYD E; FISCHER EMIL C; HASHIMOTO KOJI; FELDMAN AARON W; DIEN VIVIAN T; ZHANG YORKE
    权利人:SCRIPPS RESEARCH INST
    摘要:Disclosed herein are compositions, methods, and kits for a cell incorporating unnatural amino acids into an unnatural polypeptide. Also disclosed herein are compositions, methods, and kits for increasing activity and yield of the unnatural polypeptide synthesized by the cell.

    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-2025084410-A1
    优先权日:2015-01-12
    标 题:Incorporation of unnatural nucleotides and methods thereof
    发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
    权利人:SYNTHORX INC
    摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

    专利号:US-8778631-B2
    优先权日:2009-01-12
    标题:Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system
    发明人:VOLOSHIN ALEXEI M; ZAWADA JAMES F; GOLD DANIEL; MURRAY CHRISTOPHER JAMES; ROZZELLE JAMES EDWARD; UTER NATHAN; YIN GANG
    权利人:VOLOSHIN ALEXEI M; ZAWADA JAMES F; GOLD DANIEL; MURRAY CHRISTOPHER JAMES; ROZZELLE JAMES EDWARD; UTER NATHAN; YIN GANG; SUTRO BIOPHARMA INC
    摘要:This invention provides for a novel means of incorporating non-native amino acids into preselected positions of a protein using a cell-free synthesis system. The methods involve the use of non-orthogonal, native isoaccepting sense tRNAs that are encoded by the genetic code. Such methods allow for numerous non-native amino acids to be incorporated through the use of sense codons without having to rely upon orthogonal tRNA-synthetase pairs.

    专利号:US-4301065-A
    优先权日:1977-05-25
    标 题 :Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
    发明人:BACH JEAN-FRANCOIS; DARDENNE MIREILLE; PLEAU JEAN-MARIE; HAMBURGER JEAN; BRICAS EVANGHELOS; MARTINEZ JEAN; BLANOT DIDIER; AUGER GENEVIEVE
    权利人:ANVAR
    摘要:The invention is concerned with novel polypeptides and processes for the synthesis thereof. It is concerned with compounds having the sequence X-Gln-Gly-Gly-Y in which Y represents -Ser-Asn and X represents Ser-, Lys-Ser-, Ala-Lys-Ser-, Glx-Ala-Lys-Ser-; Glx representing Pyro-Glu or Gln; and when X represents Glx-Ala-Lys-Ser-, Y may in addition represent -Ser; as well as their derivatives comprising one or two modified amino acids, with the exception of the unmodified compound PyroGlu-Ala-Lys-Ser-Gln-Gly-Ser-Asn. These polypeptides are useful as medicines.

    专利号:US-2018371021-A1
    优先权日:2017-05-11
    标 题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00253-004-1687-2
    摘要:Ohmachi T, Narita M, Kawata M, Bizen A, Tamura Y, Asada Y. A novel N-carbamoyl-l-amino acid amidohydrolase of Pseudomonas sp. strain ON-4a: purification and characterization of N-carbamoyl-l-cysteine amidohydrolase expressed in Escherichia coli. Applied Microbiology and Biotechnology. 2004 Aug 05;65(6):686–93. doi: 10.1007/s00253-004-1687-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知